The ‘cholinic phenotype’ (apparent as increased phosphocholine and the total amount of choline-containing compounds) was shown to be related to the activation of choline kinase α (involved in a biosynthetic Kennedy pathway) and phosphatidylcholine-specific phospholipase C (participating in the phosphatidylcholine degradation pathway) in ovarian cancer [75]. Here, CHKA is linked to ovarian cancer.